PofoliaShared via Pofolia

Nature· 2020Q1

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Peng Zhou, Xing‐Lou Yang, Xian-Guang Wang, Ben Hu et al.

Short summary

A new coronavirus, 2019-nCoV, identified from an outbreak of acute respiratory syndrome in Wuhan, China, shares 96% whole-genome identity with a bat coronavirus and 79.6% sequence identity with SARS-CoV.

AI-generated from the title and abstract; the full text is not read.

Key points

  • A new coronavirus (2019-nCoV) caused an epidemic of acute respiratory syndrome in Wuhan, China.
  • By Jan 26, 2020, there were 2,794 confirmed infections and 80 deaths.
  • The virus is 96% identical to a bat coronavirus at the whole-genome level.
  • 2019-nCoV uses the same cell entry receptor (ACE2) as SARS-CoV.

AI-generated from the title and abstract; the full text is not read.

Abstract

Abstract Since the outbreak of severe acute respiratory syndrome (SARS) 18 years ago, a large number of SARS-related coronaviruses (SARSr-CoVs) have been discovered in their natural reservoir host, bats 1–4 . Previous studies have shown that some bat SARSr-CoVs have the potential to infect humans 5–7 . Here we report the identification and characterization of a new coronavirus (2019-nCoV), which caused an epidemic of acute respiratory syndrome in humans in Wuhan, China. The epidemic, which started on 12 December 2019, had caused 2,794 laboratory-confirmed infections including 80 deaths by 26 January 2020. Full-length genome sequences were obtained from five patients at an early stage of the outbreak. The sequences are almost identical and share 79.6% sequence identity to SARS-CoV. Furthermore, we show that 2019-nCoV is 96% identical at the whole-genome level to a bat coronavirus. Pairwise protein sequence analysis of seven conserved non-structural proteins domains show that this virus belongs to the species of . In addition, 2019-nCoV virus isolated from the bronchoalveolar lavage fluid of a critically ill patient could be neutralized by sera from several patients. Notably, we confirmed that 2019-nCoV uses the same cell entry receptor—angiotensin converting enzyme II (ACE2)—as SARS-CoV.

The authors' abstract, as published at the source. Nature, 2020 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Infectious Diseases

Infectious DiseasesMedicine